BioBeat is a medical-grade remote patient monitoring platform that combines wearable technology with artificial intelligence to provide continuous, real-time monitoring of vital signs. The system supports both in-hospital and out-of-hospital care, helping healthcare providers track patient health across settings and improve clinical outcomes through timely interventions.
The platform’s core offering includes FDA-cleared and CE-marked wearable devices that track multiple physiological parameters such as blood pressure, heart rate, respiratory rate, blood oxygen saturation, and more—all without the need for invasive procedures or manual measurements.
BioBeat’s advanced cloud-based analytics allow clinicians to monitor patients remotely, receive alerts about deteriorating conditions, and make data-driven decisions. It’s used in hospitals, outpatient care, and telemedicine environments to support proactive healthcare delivery and reduce hospital readmissions.
Features
Medical-Grade Wearables: BioBeat’s chest monitor and wrist monitor are FDA-cleared and CE-marked for continuous monitoring of over 15 vital signs.
Non-Invasive Blood Pressure Monitoring: The platform provides cuffless, continuous blood pressure monitoring using proprietary optical sensor technology and AI algorithms.
Remote Patient Monitoring: BioBeat enables clinicians to track patient vitals in real time from any location via its cloud dashboard, reducing the need for in-person visits.
Hospital & Home Use: The solution is suitable for both acute and chronic care settings, supporting use in ICUs, general wards, outpatient clinics, and patient homes.
Automatic Alerts: The system sends real-time notifications to healthcare providers when vital signs exceed predefined thresholds, allowing rapid intervention.
Cloud-Based Dashboard: Centralized web interface offers real-time and historical data visualization, trend analysis, and patient risk scoring.
API and EHR Integration: BioBeat integrates with hospital electronic health record systems and third-party platforms through secure APIs.
Battery Life & Comfort: The wearable devices are designed for continuous use with up to 5 days of battery life, ensuring patient comfort and uninterrupted data collection.
Contact-Free Connectivity: BioBeat wearables use Bluetooth and Wi-Fi connectivity, ensuring seamless data transmission without complex setup.
How It Works
BioBeat’s system starts with wearable sensors placed on the patient. The chest monitor is a patch-like device applied to the upper torso, while the wrist monitor functions similarly to a smartwatch. These devices use photoplethysmography (PPG) and proprietary algorithms to measure a wide range of vital signs continuously and non-invasively.
The collected data is transmitted in real time to the BioBeat cloud platform via secure wireless connections. Healthcare providers can access the data through the BioBeat dashboard, which presents a detailed view of each patient’s health status and trends.
If the system detects abnormal readings or dangerous fluctuations, it automatically sends alerts to medical staff. This allows for early detection of complications such as sepsis, respiratory failure, or cardiac issues.
Clinicians can track patient data over time, review historical trends, and make informed decisions about interventions, whether the patient is in the hospital or recovering at home.
Use Cases
In hospitals, BioBeat is used in ICUs and general wards to provide continuous, non-invasive monitoring of vital signs without requiring frequent manual measurements. This improves staff efficiency and allows for more frequent data points in patient care.
In outpatient settings and telemedicine, clinicians use BioBeat to monitor patients with chronic conditions like hypertension, heart disease, or post-surgical recovery. The platform enables ongoing care without repeated in-person visits.
BioBeat is also suitable for clinical research, allowing investigators to collect high-resolution, real-world physiological data in both controlled and natural environments.
In long-term care and rehabilitation centers, BioBeat supports early detection of health deterioration, reducing emergency hospitalizations and improving response times.
Home healthcare providers use the system to monitor elderly or high-risk patients remotely, ensuring they remain stable and allowing for proactive interventions.
Pricing
BioBeat does not display pricing details on its website. Pricing is typically customized based on the use case, number of patients monitored, deployment scale, and required integrations.
Healthcare providers, hospitals, and research institutions interested in implementing BioBeat are encouraged to contact the company directly for a tailored pricing proposal.
Enterprise-level packages may include access to devices, cloud software licenses, technical support, and integration with existing hospital systems.
Pilot programs or phased rollouts may be available for organizations seeking to evaluate the system before full deployment.
Strengths
One of BioBeat’s major strengths is its ability to deliver continuous, medical-grade vital sign monitoring without the need for cuffs, wires, or invasive devices. This makes it suitable for both high-acuity and outpatient environments.
Its FDA clearance and CE marking ensure regulatory compliance and clinical reliability, enhancing trust among healthcare providers.
The platform supports early intervention through real-time alerts and long-term trend analysis, helping reduce avoidable hospitalizations and improving patient safety.
Its dual device offering—wrist and chest monitors—gives providers flexibility depending on the clinical scenario and patient preference.
BioBeat’s focus on cloud connectivity, API support, and EHR integration makes it adaptable to different health IT infrastructures.
The system is designed for ease of use, requiring minimal patient training and enabling rapid deployment at scale.
Drawbacks
One limitation of BioBeat is that it focuses primarily on vital sign monitoring and does not currently offer advanced diagnostic features like ECG waveform analysis or lab result integration.
The system depends on consistent connectivity and cloud infrastructure, which may pose challenges in remote or low-resource environments.
As with all wearable tech, user compliance and proper device placement are crucial for accurate readings, which could be a limitation in home care settings without supervision.
The lack of publicly available pricing may be a barrier for smaller practices or research teams evaluating cost-effectiveness.
Since BioBeat is primarily geared toward enterprise healthcare organizations, it may not currently be accessible to individual users or consumer markets.
Comparison with Other Tools
BioBeat can be compared to other remote monitoring platforms such as VitalConnect, Current Health, and Biobeat’s own wrist-based competitors.
VitalConnect also offers FDA-cleared wearables for patient monitoring but focuses more on inpatient care with a patch-based ECG device. BioBeat provides a broader range of vitals with non-ECG devices that are more comfortable for long-term use.
Current Health offers a more comprehensive remote care platform with additional sensors and patient engagement tools. BioBeat focuses more specifically on continuous vital sign tracking with a lighter infrastructure footprint.
Compared to consumer-focused devices like Apple Watch or Fitbit, BioBeat offers medical-grade accuracy, regulatory approval, and real-time clinical alerts, positioning it for professional healthcare use rather than wellness tracking.
BioBeat’s strength lies in its dual-device system, AI-powered analytics, and seamless transition between hospital and home care settings.
Customer Reviews and Testimonials
While BioBeat’s website does not feature traditional customer reviews, it highlights successful clinical deployments and use cases in hospitals, research institutions, and healthcare systems worldwide.
The platform has been featured in medical journals and conferences, with clinical studies demonstrating its accuracy and utility in vital sign monitoring.
Healthcare providers using BioBeat report improvements in patient safety, care efficiency, and operational workflow, especially in environments where early detection of deterioration is critical.
BioBeat’s technology has been adopted in regions across North America, Europe, and the Middle East, and the company maintains partnerships with health systems, universities, and research centers.
Interested organizations can request case studies, whitepapers, or product demos directly from the BioBeat team.
Conclusion
BioBeat is a clinically validated, AI-powered remote patient monitoring platform that enables continuous, non-invasive tracking of vital signs in hospitals and home care settings. With FDA-cleared wearable devices, real-time alerts, and cloud-based analytics, it supports proactive healthcare delivery and improves clinical outcomes.
The platform’s ease of use, data accuracy, and regulatory compliance make it a strong choice for healthcare providers looking to expand remote monitoring capabilities without compromising on clinical standards.
Whether used in acute care, chronic disease management, or post-discharge monitoring, BioBeat helps close the gap between patient and provider by delivering meaningful, real-time health insights.
